Parvin Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Parvin Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	19,245 +480	+3%	+$27.6K	0.87%	33
2026 Q1	$1.14M	Sell	18,765 -50	-0.3%	-$2.92K	0.82%	36
2025 Q4	$1.01M	Buy	18,815 +5,990	+47%	+$288K	0.81%	37
2025 Q3	$578K	Buy	12,825 +5,490	+75%	+$256K	0.51%	62
2025 Q2	$340K	Sell	7,335 -100	-1%	-$4.91K	0.34%	83
2025 Q1	$453K	Buy	7,435 +35	+0.5%	+$2.04K	0.5%	66
2024 Q4	$419K	Buy	+7,400	New	+$413K	0.44%	69

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parvin Asset Management's BMY Position: Q2 2026 in Review

Parvin Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, buying an estimated $27.6K and bringing the position to 19,245 shares worth $1.11M. The position accounts for 0.87% of the portfolio, ranked #33.

Parvin Asset Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Parvin Asset Management held 19,245 shares of Bristol-Myers Squibb worth $1.11M as of Q2 2026.
Parvin Asset Management bought 480 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.6K.
Bristol-Myers Squibb made up 0.87% of Parvin Asset Management's portfolio in Q2 2026, its #33 holding.
Parvin Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Parvin Asset Management's Bristol-Myers Squibb position peaked at $1.14M in Q1 2026.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.